Susan L. Santangelo, ScDDirector, Center for Clinical & Translational Science
Dr. Santangelo is a psychiatric and genetic epidemiologist who joined Maine Medical Center and MaineHealth Institute for Research (MHIR) in 2013. She also directs the Clinical Research Design, Epidemiology and Biostatistics Core of the Northern New England Clinical and Translational Research Network (NNE-CTR), based at MHIR and The University of Vermont.
Dr. Rosen is a world-renowned researcher in the field of bone metabolism. His laboratory focuses on the study of marrow adiposity and bone formation and he has over twenty years of experience with NIH-funded clinical trials. Dr. Rosen has served on numerous NIH review panels and as editor of scientific journals; he is currently an associate editor at the New England Journal of Medicine and is a standing member of the FDA Endocrinologic and Metabolic Diseases Advisory Committee.
Ivette Emery, PhDProgram Director, Center for Clinical & Translational Science
Dr. Emery has over 10 years of experience as a clinical and translational researcher. She has participated in the development and launch of over 30 study protocols involving human participants. Dr. Emery also serves as the Associate Lead of the Professional Development Core of the Northern New England Clinical and Translational Research (NNE-CTR) Network and has developed and implemented training programs for early clinical investigators and research navigators.
Robert Ecker, MD
Dr. Ecker is a neurosurgeon, the Director of the Neuroscience Institute at Maine Medical Center and Principal Site Investigator on several aneurysm and stroke intervention clinical trials, including the national Swift-Prime Study, which treats stroke victims with a promising tool that removes clots from the brain immediately following stroke.
Kathleen Fairfield, MD, MPH, DrPH
Dr. Fairfield is a Physician Scientist, and Associate Professor of Medicine, Public Health & Community Medicine at Tufts University School of Medicine. After serving on the faculty at Beth Israel Deaconess Medical Center, Dr. Fairfield joined Maine Medical Center (MMC) in 2002. Dr. Fairfield’s previous research is at the intersection of health services research, improvement science in health care delivery, and population health.
Tom Gridley, PhD
Dr. Gridley has over thirty years of experience studying genes and pathways important for embryonic development in mammals, and the connections between mutations in these genes and congenital and acquired human disease. Dr. Gridley has served on numerous NIH review panels, has been Director of an institutional training grant in developmental genetics, and is the Associate Director of the Acute Care COBRE and Vice Chair of the MMC Institutional Review Board..
Robert Kramer, MD
Dr. Kramer is a cardiothoracic surgeon who serves as Associate Director of the MMC Blood Management Program. His research interests include neuropsychological changes associated with cardiopulmonary bypass, perioperative glucose and blood management and cardiac surgery associated with acute kidney injury.
Susan Miesfeldt, MD
Dr. Miesfeldt is the Medical Director for the Cancer Risk and Prevention Program at MMC. Her research focuses on improving access to cancer prevention and early detection among the underserved as well as genetic risks of cancer, the use of telegenetics as a model of care, and studies of biomarkers of breast cancer to improve early detection and treatment.
Kahsi A. Pedersen, PhD
Kahsi Pedersen is a behavioral scientist and Staff Scientist at Maine Medical Center (MMC) and Co- Director of the MHIR Clinical and Translational Research Course. Dr. Pedersen has extensive experience with statistical consulting and advanced structural equation modeling as well as other methods of data reduction, path analysis, and analysis of latent variables.
Joseph Rappold, MD
Dr. Rappold is chief of the division of acute care surgery at MMC who is studying the extremes of trauma and hemorrhagic shock and their impact on hemostasis and potential recovery.
David Seder, MD
Dr. Seder, is Director of the Division of Neuro-critical Medicine at MMC. He investigates ways to minimize brain injury following cardiac arrest and stroke. See www.setpoint2.org to learn more about Dr. Seder’s study.
Matthew Siegel, MD
Dr. Siegel, is a pediatric psychiatrist at Maine Behavioral Healthcare and Director of the Autism and Developmental Disorder Inpatient Research Collaborative. His research focus is on assessment and intervention for challenging behaviors in youth severely affected by Autism Spectrum Disorder.
Doug Sawyer, MD, PhD
Dr. Sawyer is the Co-Director of the Myocardial Biology & Heart Failure Research Lab and is the Chief of Cardiovascular Services at Maine Medical Center. His research centers on developing therapeutic strategies to enhance myocardial repair after injury.
Brianna Taylor, PhD
Briana Taylor’s research has focused on associations between sleep patterns and both bio-behavioral and mental-health. Her current focus is to examine sleep patterns and circadian physiology as predictors of adaptive functioning in children and adolescents with autism spectrum disorder (ASD).
Kristen A. Woodberry, MSW, PhD
Kristen Woodberry is a clinical social worker, licensed clinical psychologist, and early psychosis researcher at the MaineHealth Institute for Research and Beth Israel Deaconess Medical Center. With over 25 years of clinical experience with children, adolescents, and families, including pioneering work adapting multifamily psychoeducational group therapies for adolescents and their families, Dr. Woodberry’s research has focused on early intervention in major mental illness.
Jonathan Zuckerman, MD
Dr. Zuckerman is Director of the Adult Cystic Fibrosis Program at MMC. He has a longstanding interest in therapeutic development for cystic fibrosis, and has conducted clinical trials on gene therapy for cystic fibrosis, and on outpatient infection control in adult and pediatric cystic fibrosis programs. He currently collaborates on several projects to define best practices in cystic fibrosis care, including evaluation of novel biomarkers, use of probiotics, and risk factors for venous catheter complications.
From our laboratories to the bedside, research is an essential part of MaineHealth’s mission.